Connect Biopharma to Highlight Innovations at September Conferences
Connect Biopharma's Upcoming Investor Engagements
Connect Biopharma Holdings Limited (NASDAQ: CNTB), a prominent clinical-stage biopharmaceutical company focusing on improving the treatment landscape for inflammatory diseases, has exciting news regarding its participation in two key investor conferences. These conferences provide an excellent platform for the Company to connect with investors and share valuable insights about its ongoing projects and innovations in the healthcare sector.
Cantor Global Healthcare Conference
An Insightful Fireside Chat
As part of its conference schedule, Connect Biopharma will participate in the Cantor Global Healthcare Conference. This event is set for September 3, 2025, at 3:20 p.m. ET. Attendees can look forward to a dynamic fireside chat format, allowing for an interactive dialogue about the Company’s vision and product pipeline.
H.C. Wainwright 27th Annual Global Investment Conference
Following the Cantor Conference, Connect Biopharma will also be featured at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 9:30 a.m. ET. This conference promotes a rich environment for networking and learning about cutting-edge advancements in biopharmaceuticals, particularly in areas involving asthma and COPD management.
Accessing Live Presentations
For those interested in following along, live access to the webcasts of these important presentations will be made available via the Investors section of the Connect Biopharma website. Archived recordings will also be provided for approximately 90 days after each conference, ensuring that investors can revisit these discussions at their convenience.
Company Overview
Founded to revolutionize treatment approaches for chronic diseases, Connect Biopharma is currently advancing rademikibart, a next-generation monoclonal antibody targeting IL-4R?. This innovative therapy is undergoing global clinical trials aimed at addressing significant unmet needs in asthma and COPD. Additionally, the Company holds an exclusive collaboration with Simcere in China, further emphasizing its commitment to expanding access to critical treatments.
Contact Information
For additional inquiries, interested parties can reach out to:
Investor Relations Contact:
Alex Lobo
Precision AQ
alex.lobo@precisionaq.com
(212) 698-8802
Media Contact:
Ignacio Guerrero-Ros, Ph.D., or David Schull
Russo Partners, LLC
ignacio.guerrero-ros@russopartnersllc.com
(858) 717-2310 or (646) 942-5604
Frequently Asked Questions
What is the purpose of the upcoming conferences for Connect Biopharma?
The upcoming conferences are platforms for Connect Biopharma to present its innovative treatments and engage with potential investors.
When is Connect Biopharma participating in the conferences?
They will participate in the Cantor Global Healthcare Conference on September 3, 2025, and the H.C. Wainwright Conference on September 8, 2025.
How can I access the live presentations from these conferences?
Live presentations will be available through the Investors section of the Connect Biopharma website, along with archived recordings for later access.
What is rademikibart?
Rademikibart is Connect Biopharma’s promising therapy aimed at treating asthma and COPD by targeting the IL-4R? receptor.
Who should I contact for more information?
For investor inquiries, reach Alex Lobo at Precision AQ, and for media inquiries, contact Ignacio Guerrero-Ros at Russo Partners, LLC.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.